1,000
Participants
Start Date
August 3, 2024
Primary Completion Date
August 3, 2025
Study Completion Date
February 3, 2026
TEMPUS AI-enabled ECG-based Screening Tool
The AI-enabled ECG-based screening tool, Tempus Next software, analyzes 12-lead ECG recordings to identify patients at increased risk for undiagnosed cardiovascular diseases, specifically atrial fibrillation (AF) and structural heart disease (SHD). Clinicians in the intervention group will receive a risk assessment for AF and SHD each time they order an ECG for their patients.
Northwestern University, Chicago
Northwestern University
OTHER